Mode
Text Size
Log in / Sign up
N/A N=168

Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest

Post-Resuscitation Syndrome · Critical Illness · Cardiac Arrest · Hypoxic-Ischemic Encephalopathy · Coma

Enrolled (actual)
168
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: 30-Day Mortality — 112 participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Ahmet Düzgün
Primary completion
Dec 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
30-Day Mortality
112
SECONDARY
In-Hospital Mortality
87
SECONDARY
6-Month Mortality
130

Summary

This retrospective observational cohort study aims to identify early predictors of short- and mid-term mortality in adult patients who achieved return of spontaneous circulation (ROSC) after cardiac arrest. Eligible patients admitted to the intensive care unit between January 1, 2024 and May 31, 2025 were identified retrospectively from electronic medical records following institutional ethics approval. Clinical, biochemical, and resuscitation-related parameters recorded within the first 24 hours of ICU admission were analyzed. The primary objective was to determine factors independently associated with short-term mortality. Six-month mortality was additionally assessed using hospital records and the national death registry. The findings are expected to improve risk stratification and clinical decision-making in post-cardiac arrest care.

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Achieved return of spontaneous circulation (ROSC) after cardiac arrest
  • Admitted to the intensive care unit (ICU)
  • Informed consent obtained from patient or legal representative (if applicable)

Exclusion Criteria

  • Age < 18 years
  • Known pregnancy
  • Brain death at the time of ICU admission
  • Patients with missing key clinical or laboratory data
  • Declined participation or legal refusal
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07020091). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search